IBEX Proxy Seeks 1M-Share LTIP Increase and Lower Bye-Law Vote Threshold
IBEX sits 76% above its 52-week low of $25.94.
Summary
IBEX's preliminary proxy asks shareholders to approve a 1,000,000-share increase to its long-term incentive plan (10.6% potential basic dilution) and to lower the bye-law amendment approval threshold from 75% to a simple majority. The filing also discloses the loss of emerging growth company status and multiple late Section 16 filings by executives.
Key Events · Corporate Governance and Compliance · IBEX
-
1M-Share LTIP Increase Proposed
Shareholders are asked to approve an additional 1,000,000 common shares for the 2020 Long-Term Incentive Plan, raising the aggregate reserve to 3,637,326.13 shares. As of October 9, 2026, only 460,424 shares remained available.
-
10.6% Potential Basic Dilution
The company calculates 10.6% potential basic dilution from remaining plus requested shares (1,411,020 / 13,309,640) and 19.8% total potential overhang including outstanding awards. This authorization issues no shares; grants remain at the Compensation Committee's discretion.
-
Bye-Law Threshold Cut to Simple Majority
Proposal 6 would amend Bye-law 74 to replace the current 75% shareholder approval requirement for bye-law amendments with a simple majority, making future governance changes easier to pass.
-
Emerging Growth Company Status Lost
IBEX ceased to qualify as an emerging growth company as of June 30, 2026, triggering expanded executive compensation disclosure including the first Pay Versus Performance table covering three fiscal years.
Analysis · IBEX · Technology
The preliminary proxy for IBEX's December 10 annual meeting asks shareholders to approve a 1,000,000-share increase to the 2020 Long-Term Incentive Plan, lifting the aggregate reserve to 3,637,326.13 shares. With 13,309,640 shares outstanding, the company itself calculates 10.6% potential basic dilution from the remaining plus requested shares and 19.8% total potential overhang including outstanding awards. The shares would not be issued immediately; the reserve is authorization for future grants, and the company says it expects the pool to last about three years at current grant rates. A separate proposal would cut the shareholder approval threshold for bye-law amendments from 75% to a simple majority, a governance change that makes future charter-level changes easier to pass. The proxy also discloses that IBEX lost emerging growth company status as of June 30, 2026, which triggered the first Pay Versus Performance disclosure and expanded compensation reporting. Notably, the filing discloses late Section 16 reports from multiple insiders, including three late Form 4s each for the CEO and CFO, a compliance lapse worth flagging alongside the heavy insider selling already visible in the timeline.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 29.5% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IBEX was trading at $45.65 on NASDAQ in the Technology sector, with a market capitalization of approximately $606.1M. The 52-week trading range was $25.94 to $47.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.